SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-24-089689
Filing Date
2024-10-22
Accepted
2024-10-22 16:51:14
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0216567-f3_chinasxtpharma.htm F-3 251821
2 FORM OF INDENTURE WITH RESPECT TO SENIOR DEBT SECURITIES, TO BE ENTERED INTO BET ea021656701ex4-4_china.htm EX-4.4 332827
3 FORM OF INDENTURE WITH RESPECT TO SUBORDINATED DEBT SECURITIES, TO BE ENTERED IN ea021656701ex4-5_china.htm EX-4.5 306825
4 OPINION OF CAMPBELLS LEGAL (BVI) LIMITED ea021656701ex5-1_china.htm EX-5.1 25134
5 CONSENT OF ZH CPA ea021656701ex23-1_china.htm EX-23.1 3977
6 FILING FEE TABLE ea021656701ex-fee_china.htm EX-FILING FEES 20498
7 GRAPHIC ex5-1_001.jpg GRAPHIC 11081
8 GRAPHIC ex23-1_001.jpg GRAPHIC 19995
  Complete submission text file 0001213900-24-089689.txt   985169
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: F-3 | Act: 33 | File No.: 333-282776 | Film No.: 241386832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)